Skip to content

Screener

Eligibility screening

Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic…

Sponsored by M.D. Anderson Cancer CenterStudy detailsClinicalTrials.gov

1 US site in TX

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.